The Food and Drug Administration has issued a new warning about a rare eye condition associated with GLP-1 medications, raising questions about the potential risks for patients.
Here & Now‘s Indira Lakshmanan speaks with Elaine Chen, a biotech reporter for our editorial partner STAT, about the findings and whether patients should be concerned.
This article was originally published on WBUR.org.
Copyright 2026 WBUR